iBio (IBIO) Receivables - Other (2016 - 2021)
iBio (IBIO) has disclosed Receivables - Other for 7 consecutive years, with $1000.0 as the latest value for Q1 2021.
- On a quarterly basis, Receivables - Other changed N/A to $1000.0 in Q1 2021 year-over-year; TTM through Mar 2021 was $1000.0, a N/A change, with the full-year FY2016 number at $122000.0, changed N/A from a year prior.
- Receivables - Other was $1000.0 for Q1 2021 at iBio, down from $52000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $15.0 million in Q3 2017 to a low of $1000.0 in Q1 2021.
- A 4-year average of $7.5 million and a median of $7.5 million in 2017 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: surged 24093.55% in 2017, then changed 0.0% in 2018.
- iBio's Receivables - Other stood at $15.0 million in 2017, then plummeted by 99.62% to $57000.0 in 2018, then decreased by 8.77% to $52000.0 in 2020, then plummeted by 98.08% to $1000.0 in 2021.
- Per Business Quant, the three most recent readings for IBIO's Receivables - Other are $1000.0 (Q1 2021), $52000.0 (Q4 2020), and $57000.0 (Q4 2018).